TY - JOUR
T1 - Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease
AU - Zhang, Bin
AU - Gaiteri, Chris
AU - Bodea, Liviu Gabriel
AU - Wang, Zhi
AU - McElwee, Joshua
AU - Podtelezhnikov, Alexei A.
AU - Zhang, Chunsheng
AU - Xie, Tao
AU - Tran, Linh
AU - Dobrin, Radu
AU - Fluder, Eugene
AU - Clurman, Bruce
AU - Melquist, Stacey
AU - Narayanan, Manikandan
AU - Suver, Christine
AU - Shah, Hardik
AU - Mahajan, Milind
AU - Gillis, Tammy
AU - Mysore, Jayalakshmi
AU - MacDonald, Marcy E.
AU - Lamb, John R.
AU - Bennett, David A.
AU - Molony, Cliona
AU - Stone, David J.
AU - Gudnason, Vilmundur
AU - Myers, Amanda J.
AU - Schadt, Eric E.
AU - Neumann, Harald
AU - Zhu, Jun
AU - Emilsson, Valur
N1 - Funding Information:
Additional tissues include samples from the following sites: The Kathleen Price Bryan Brain Bank, Duke University Medical Center (NIA grant #AG05128, NINDS grant # NS39764, NIMH MH60451 also funded by Glaxo Smith Kline): Christine Hulette, MD, Director, John F. Ervin University of Michigan (NIH grant P50-AG08671): Dr. Roger Albin, Lisa Bain, Eszter Gombosi, Sun Health Research Institute Brain Donation Program of Sun City, Arizona (NIA #P30 AG19610; Arizona Alzheimer’s Disease Core Center, Arizona Department of Health Services, contract 211002, Arizona Alzheimer’s Research Center; Arizona Biomedical Research Commission, contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson’s Disease Consortium; Michael J. Fox Foundation for Parkinson’s Research): Joseph Rogers, PhD, Thomas G. Beach, MD, PhD, Lucia I. Sue University of Miami/NPF Brain Endowment Bank: Deborah C. Mash, MD, Margaret J. Basile, Mitsuko Tanaka Oregon Health & Science University: Randy Wotljer, PhD Newcastle Brain Tissue Resource (funding via the Medical Research Council, local NHS trusts and Newcastle University): C.M. Morris, MD, Ian G McKeith, Robert H. Perry MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council): Simon Lovestone, Md PhD, Safa Al-Sarraj. MD, Claire Troakes, South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimer’s Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and DeNDRoN): Seth Love, MD, Patrick Kehoe, PhD, Laura Palmer, The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek): Inge Huitinga, MD, Marleen Rademaker, Michiel Kooreman, Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona: Isidre Ferrer Abizanda, MD, PhD, Susana Casas Boluda.
Funding Information:
H.N. and L.-G.B. were supported by the Hertie-Foundation and the Deutsche Forschungsgemeinschaft (FOR1336, SFB704, KFO177). H.N. is a member of the DFG-funded excellence cluster ImmunoSensation. We thank Jessica Schumacher and Rita Hass for technical assistance. We are grateful to the HBTRC for the generous gift of human postmortem brain samples. The authors are also grateful to the participants in the Religious Orders Study and the Memory and Aging Project. This work is supported by the National Institutes of Health (R01 AG034504, R01 AG030146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290, P30 AG10161, R01 AG11101, and NS032765), the Illinois Department of Public Health, and start-up funding from the University of Miami, Miller School of Medicine. J.M., A.A.P., C.Z., T.X., R.D., E.F., S.M., M.N., C.M., and D.J.S. are employees and shareholders of Merck & Co., Inc. J.R.L. is an employee and shareholder of Novartis.
PY - 2013/4/25
Y1 - 2013/4/25
N2 - The genetics of complex disease produce alterations in the molecular interactions of cellular pathways whose collective effect may become clear through the organized structure of molecular networks. To characterize molecular systems associated with late-onset Alzheimer's disease (LOAD), we constructed gene-regulatory networks in 1,647 postmortem brain tissues from LOAD patients and nondemented subjects, and we demonstrate that LOAD reconfigures specific portions of the molecular interaction structure. Through an integrative network-based approach, we rank-ordered these network structures for relevance to LOAD pathology, highlighting an immune- and microglia-specific module that is dominated by genes involved in pathogen phagocytosis, contains TYROBP as a key regulator, and is upregulated in LOAD. Mouse microglia cells overexpressing intact or truncated TYROBP revealed expression changes that significantly overlapped the human brain TYROBP network. Thus the causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.
AB - The genetics of complex disease produce alterations in the molecular interactions of cellular pathways whose collective effect may become clear through the organized structure of molecular networks. To characterize molecular systems associated with late-onset Alzheimer's disease (LOAD), we constructed gene-regulatory networks in 1,647 postmortem brain tissues from LOAD patients and nondemented subjects, and we demonstrate that LOAD reconfigures specific portions of the molecular interaction structure. Through an integrative network-based approach, we rank-ordered these network structures for relevance to LOAD pathology, highlighting an immune- and microglia-specific module that is dominated by genes involved in pathogen phagocytosis, contains TYROBP as a key regulator, and is upregulated in LOAD. Mouse microglia cells overexpressing intact or truncated TYROBP revealed expression changes that significantly overlapped the human brain TYROBP network. Thus the causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.
UR - http://www.scopus.com/inward/record.url?scp=84876907931&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2013.03.030
DO - 10.1016/j.cell.2013.03.030
M3 - Article
C2 - 23622250
AN - SCOPUS:84876907931
SN - 0092-8674
VL - 153
SP - 707
EP - 720
JO - Cell
JF - Cell
IS - 3
ER -